Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-05-31 · accession 0001127602-24-017958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-05 | 2024-05-31 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +108.1K | 990.8K | +12% | — |
| D | 2024-06-05 | 2024-06-03 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $0.55 | -48.9K | 984.7K | -5% | -$26.9K |
| DM | 2024-06-05 | 2024-05-31 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -108.1K | 1.03M | -9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-31 | M | A | 1,638 | — | 1,033,528 | D | — | — | (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 2 | Common | Class A Common Stock | 2024-05-31 | M | A | 22,917 | — | 1,031,890 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 3 | Common | Class A Common Stock | 2024-06-03 | S | D | 48,866 | $0.55 | 984,662 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-05-31 | M | A | 18,125 | — | 1,008,973 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 5 | Common | Class A Common Stock | 2024-05-31 | M | A | 65,448 | — | 990,848 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 6 | Derivative | Class B Common Stock | 2024-05-31 | M | D | 1,638 | — | 625,412 | D | — · — to — | 1,638 Class A Common Stock | (F7) Includes shares of Class B Common Stock that are subject to vesting conditions. (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 7 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 18,125 | — | 598,125 | D | — · — to — | 18,125 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F5) The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| 8 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 65,448 | — | 581,538 | D | — · — to — | 65,448 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 9 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 22,917 | — | 1,031,250 | D | — · — to — | 22,917 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F6) The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |